Prevent Risks by Early interVEntion at Nighttime in Type 1 diabetes for Kidney Disease (PREVENTKD)
Researchers at Northwestern University are recruiting subjects for a trial to prevent the development of kidney disease in people with type I diabetes. The study’s main goal is to see if early treatment with ACE inhibitors (a widely prescribed type of blood pressure medication that has protective effects on the kidney) is beneficial to prevent the kidney complication of diabetes called microalbuminuria (abnormal spilling of protein in the urine).
Who is Eligible?
- Are between the ages of 13-50
- Have had type 1 diabetes for 5-28 years
- Have normal blood pressure
- Have no evidence of kidney disease
What do study participants have to do?
- Study participants will either receive the study drug or placebo nightly
- 24 hour ambulatory (home) blood pressure recording
- Others tests from urine and blood samples
How will I be compensated?
- $50 per visit plus additional compensation for optional procedures
How do I get more information?
Please contact our study coordinator by telephone at 312-503-2183, Monday – Friday 8 AM - 5 PM for additional information or visit our website at www.preventkd.com.
October 29, 2008
[ Back to Studies Page ]
|Return to the Top of This Page|
Last Updated: Wednesday October 29, 2008 14:08:54
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.